DPP4 and diabetes mellitus: Indeed, we reported that both DPP-4 inhibitor and GLP-1RA had a protective effect against β-cell dysfunction in a diabetic rodent model (22–24) and that the effectiveness was more remarkable at the early phase of diabetes compared with the advanced stage of diabetes (24).